Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT)

Duration:

01.10.2015 - 30.09.2018

Unit at THL:

Unit for Viral Infections

On other websites:

HA-REACT addresses existing gaps in the prevention of HIV and co-infections (especially tuberculosis and hepatitis) among people who inject drugs.

Objectives

The purpose of the project is: Improved capacity to respond to HIV and co-infection risks and provide harm reduction with specific focus on people who inject drugs (PWID) in the EU.

Implementation

The project includes eight work packages: Coordination, Dissemination, Evaluation, Testing and linkage to care, Scaling up harm reduction, Harm reduction and continuity of care in prisons, Integrated care, and Sustainability and long-term funding.

Funding

EU Health Programme 80%

National Ministries of Health and Associated partner organisations 20%

Partners

Associated partners from Croatia, Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hungary, Iceland, Italy, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Slovenia and Spain (23 associated partners).

Twelve ollaborating partners  - among them ECDC, EMCDDA, organisations from Norway, Sweden and UK.

Coordinated by THL. 

Contact information

Ms Outi Karvonen
Project Manager
Phone: +358 29 524 7046
E-mail: [email protected]